476 related articles for article (PubMed ID: 37627173)
41. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
[TBL] [Abstract][Full Text] [Related]
42. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
[TBL] [Abstract][Full Text] [Related]
43. The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression.
Buruiană A; Gheban BA; Gheban-Roșca IA; Georgiu C; Crișan D; Crișan M
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730679
[TBL] [Abstract][Full Text] [Related]
44. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
45. Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma.
Luo W; Zhang T
Cancer Lett; 2023 Jul; 567():216279. PubMed ID: 37336287
[TBL] [Abstract][Full Text] [Related]
46. Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion.
Yamaguchi H; Sakai R
Cancers (Basel); 2015 Oct; 7(4):2054-62. PubMed ID: 26473929
[TBL] [Abstract][Full Text] [Related]
47. Cancer-associated fibroblasts: The chief architect in the tumor microenvironment.
Sarkar M; Nguyen T; Gundre E; Ogunlusi O; El-Sobky M; Giri B; Sarkar TR
Front Cell Dev Biol; 2023; 11():1089068. PubMed ID: 36793444
[TBL] [Abstract][Full Text] [Related]
48. Stromal integrin α11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors.
Smeland HY; Lu N; Karlsen TV; Salvesen G; Reed RK; Stuhr L
BMC Cancer; 2019 Mar; 19(1):234. PubMed ID: 30876468
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment.
Tanaka HY; Nakazawa T; Enomoto A; Masamune A; Kano MR
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765684
[TBL] [Abstract][Full Text] [Related]
50. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
51. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment.
Prieto-Fernández L; Montoro-Jiménez I; de Luxan-Delgado B; Otero-Rosales M; Rodrigo JP; Calvo F; García-Pedrero JM; Álvarez-Teijeiro S
Biomed Pharmacother; 2023 May; 161():114502. PubMed ID: 37002578
[TBL] [Abstract][Full Text] [Related]
52. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
[TBL] [Abstract][Full Text] [Related]
53. Cancer associated fibroblasts: the dark side of the coin.
Cirri P; Chiarugi P
Am J Cancer Res; 2011; 1(4):482-97. PubMed ID: 21984967
[TBL] [Abstract][Full Text] [Related]
54. Stromal disruption facilitating invasion of a 'nano-arsenal' into the solid tumor.
Fu Y; Saraswat AL; Monpara J; Patel K
Drug Discov Today; 2022 Apr; 27(4):1132-1141. PubMed ID: 34823002
[TBL] [Abstract][Full Text] [Related]
55. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
56. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
[TBL] [Abstract][Full Text] [Related]
57. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
[TBL] [Abstract][Full Text] [Related]
58. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.
Koontongkaew S
J Cancer; 2013; 4(1):66-83. PubMed ID: 23386906
[TBL] [Abstract][Full Text] [Related]
59. Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy.
Xu X; Wu Y; Qian X; Wang Y; Wang J; Li J; Li Y; Zhang Z
Adv Healthc Mater; 2022 Jan; 11(1):e2101428. PubMed ID: 34706400
[TBL] [Abstract][Full Text] [Related]
60. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.
Erdogan B; Webb DJ
Biochem Soc Trans; 2017 Feb; 45(1):229-236. PubMed ID: 28202677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]